-+ 0.00%
-+ 0.00%
-+ 0.00%

LUNAI BIOWORKS (NASDAQ: LNAI) LAUNCHES AI ONCOLOGY PILOT WITH CLINICAL-STAGE PARTNER TO ANALYZE RANDOMIZED PHASE 2 METASTATIC COLORECTAL CANCER SURVIVAL TRIAL DATA

Reuters·02/09/2026 14:15:00

Please log in to view news